Product Information

MEFLOQUINE HCL 250 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $3.5498 per EA under NDC 62135097325. Its NADAC has been published 85 times since Apr 9, 2025.

FDA first approved this application on Feb 20, 2002. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

MEFLOQUINE HCL 250 MG TABLET

Mefloquine Hydrochloride
$3.5498per EA

Strength

250 mg/1

Manufacturer

Chartwell RX LLC

NDC

62135097325

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

MEFLOQUINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA076175

FDA Approved

2/20/2002

TE Code

AB

On Market Since

2/20/2022

Pharmacological Classes

Price Statistics

The NADAC for MEFLOQUINE HCL 250 MG TABLET has been published 85 times since Apr 9, 2025, and over the history we have for it it has risen 13.1%. The table below summarizes its recorded NADAC range and movement.

Current price$3.5498 per EA
All-time high$5.0310 (Oct 15, 2025)
All-time low$3.1377 (Apr 9, 2025)
52-week high$4.8735
52-week low$3.5498
Median price$4.1565
Average price$4.1196
Largest weekly change+52.2% (Aug 20, 2025)
Weeks tracked85
Tracking sinceApr 9, 2025

Price History

1W

-4.9%

1M

-10.7%

3M

-14.3%

6M

-14.6%

1Y

-27.2%

3Y

N/A

5Y

N/A

All

+13.1%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of MEFLOQUINE HCL 250 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for MEFLOQUINE HCL 250 MG TABLET, manufactured by Chartwell RX LLC, is $3.5498 per EA (NDC 62135097325), effective Nov 18, 2026.

How has the price of MEFLOQUINE HCL 250 MG TABLET changed over time?

Over the history we have for it, the NADAC for MEFLOQUINE HCL 250 MG TABLET has risen 13.1%. It has been tracked across 85 weekly CMS publications since Apr 9, 2025.

What are the highest and lowest recorded NADAC prices for MEFLOQUINE HCL 250 MG TABLET?

Since Apr 9, 2025, the NADAC for MEFLOQUINE HCL 250 MG TABLET has ranged from a low of $3.1377 (Apr 9, 2025) to a high of $5.0310 (Oct 15, 2025), with a median of $4.1565 per EA.

Are there cheaper alternatives to MEFLOQUINE HCL 250 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as MEFLOQUINE HCL 250 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures MEFLOQUINE HCL 250 MG TABLET?

MEFLOQUINE HCL 250 MG TABLET (NDC 62135097325) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.